Back to Results
First PageMeta Content
Healthcare in Australia / Pharmaceuticals policy / Pharmaceutical Benefits Scheme / Quality use of medicines / Drug safety / Fingolimod / Cetuximab / Pharmacovigilance / Antipsychotic / Medicine / Pharmacology / Health


Drug Utilisation Sub-Committee Outcome Statement 6-7 June 2013 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 78th meeting on 6-7 June[removed]DUSC is a national
Add to Reading List

Document Date: 2015-03-13 00:20:02


Open Document

File Size: 127,64 KB

Share Result on Facebook

Country

United States / Australia / /

/

IndustryTerm

dose combination products / online publication / management tool / combination products / /

MedicalCondition

Pseudomonas / COPD / schizophrenia / multiple myeloma / Disease / chronic renal failure / chronic obstructive pulmonary disease / metastatic colorectal cancer / bone metastasis / multiple sclerosis / Osteoporosis / aeruginosa infection / benign prostatic hyperplasia / severe primary axillary hyperhidrosis / resistant prostate cancer / cystic fibrosis / breast cancer / bipolar disorder / /

MedicalTreatment

alternate therapies / /

Organization

DUSC Secretariat / Pharmaceutical Benefits Advisory Committee / National Park Service / Council of Australian Therapeutic Advisory Groups / National Science Foundation / Generic Medicines Industry Association / PBAC DUSC / Medicare / /

Person

Geoff McColl / Belinda Wood / Elizabeth de Somer / Torres Strait Islander / /

Position

Governor / Professor / /

Product

tamsulosin / risperidone / Denosumab injection / Tobramycin / /

Technology

pdf / /

URL

http /

SocialTag